Rhenman & Partners Asset Management Ab IMMUNOMEDICS INC Transaction History

Rhenman & Partners Asset Management Ab

$1.01 Billion
Q2 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Jan 19, 2021	SELL	N/A	-221,351 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	N/A	-238,649 Reduced 51.88%	221,351 $18.8 Million
Q2 2020 Jul 16, 2020	SELL	N/A	-130,000 Reduced 22.03%	460,000 $16.3 Million
Q1 2020 Apr 16, 2020	SELL	N/A	-110,000 Reduced 15.71%	590,000 $7.95 Million
Q4 2019 Jan 17, 2020	SELL	N/A	-150,000 Reduced 17.65%	700,000 $14.8 Million
Q3 2019 Oct 16, 2019	SELL	N/A	-1,367 Reduced 0.16%	850,000 $11.3 Million
Q2 2019 Jul 22, 2019	BUY	N/A	235,000 Added 38.13%	851,367 $11.8 Million
Q1 2019 Apr 11, 2019	BUY	N/A	136,037 Added 28.32%	616,367 $11.8 Million
Q4 2018 Feb 05, 2019	BUY	N/A	55,000 Added 12.93%	480,330 $6.85 Million
Q3 2018 Oct 03, 2018	SELL	N/A	-30,000 Reduced 6.59%	425,330 $8.86 Million
Q2 2018 Jul 20, 2018	BUY	N/A	40,000 Added 9.63%	455,330 $10.8 Million
Q1 2018 Apr 11, 2018	SELL	N/A	-65,000 Reduced 13.53%	415,330 $6.07 Million
Q4 2017 Jan 19, 2018	SELL	N/A	-19,670 Reduced 3.93%	480,330 $7.76 Million
Q3 2017 Oct 13, 2017	BUY	N/A	500,000	500,000 $6.99 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.